Related Experiment Video

Updated: Jul 2, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

Molecular mechanisms underlying the transition of cardiac hypertrophy to heart failure

Toru Oka1, Issei Komuro

  • 1Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Circulation Journal : Official Journal of the Japanese Circulation Society
|September 6, 2008
PubMed

Insights

Understanding heart failure progression is key to developing new treatments. This review explores cardiac myocyte loss, calcium handling, and ischemia/hypoxia as critical factors in heart failure development.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pathophysiology

Background:

  • Heart failure is a major global health concern and a common outcome of heart disease.
  • Despite advances, the molecular mechanisms driving the transition from cardiac hypertrophy to heart failure remain unclear.
  • Current therapies have improved outcomes, but heart failure persists as a leading cause of mortality.

Purpose of the Study:

  • To review and discuss the potential molecular mechanisms underlying heart failure progression.
  • To elucidate the transition from cardiac hypertrophy to heart failure.
  • To identify novel therapeutic targets for heart diseases.

Main Methods:

  • Literature review focusing on molecular and cellular processes in heart failure.
  • Analysis of mechanisms including cardiac myocyte loss, calcium handling, and myocardial ischemia/hypoxia.
  • Synthesis of information on the cooperative roles of these factors in disease pathogenesis.

Main Results:

  • Cardiac myocyte loss contributes to heart failure progression.
  • Abnormalities in calcium handling play a significant role in contractile dysfunction.
  • Myocardial ischemia and hypoxia are critical factors in the development of heart failure.
  • These mechanisms interact to promote heart failure.

Conclusions:

  • Cardiac myocyte loss, calcium handling abnormalities, and ischemia/hypoxia are key contributors to heart failure progression.
  • Understanding these interconnected mechanisms is crucial for developing effective treatments.
  • Further research into these molecular pathways will enable novel therapeutic strategies for heart diseases.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...